drug discovery ai

The drug discovery ai tag follows applied AI in pharmaceutical research, with current coverage focused on Astellas’ use of NVIDIA Boltz-2 NIM for membrane-protein drug discovery. The reported workflow uses Tokyo-1 as a computational foundation and presents results through production infrastructure and a browser-based interface intended for chemists as well as computational specialists. The featured deployment evaluated fewer compounds while reporting that all 10 selected compounds showed the expected medicinal effects. Astellas also reported reductions of more than 90% in evaluated compounds and more than 70% in research time, illustrating how scientific models can support practical, enterprise-scale drug research.